Drawing for CAMTECH

USPTO serial 88900698

CAMTECH

Reviewed by CopyMark Law Group

Reg. 6473975Status 700Renewal
Filing date
Status date
Registration date
Sep 7, 2021
Examiner
ROCCA, ALAINA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CAMTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,544*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keesonga Gore

Keesonga Gore MINOTT GORE, P.A.201 S. BISCAYNE BLVD.SUITE 2800MIAMI, FL 33131

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for clinical use; Diagnostic preparations for scientific use, namely, chemicals for use in antibiotic susceptibility testing; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations, except for medical or veterinary use; Diagnostic preparations used in science; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents, except for medical or veterinary use; Diagnostic reagents, other than for medical laboratory use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic preparations for scientific or research use other than for medical use, namely, scanning agents for in-vivo use; Diagnostic preparations for scientific use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Diagnostic reagent for scientific use; Diagnostic reagents for clinical or medical laboratory useACTIVE—
005Diagnostic agents for medical use; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations, namely, chemical reagents for medical use; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic reagents for medical use; Diagnostic substances for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In vitro gender prediction test kit; Reagents and media for medical and veterinary diagnostic purposes; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic test strips for blood analysisACTIVE—
009Downloadable computer software systems for remote diagnostics; Diagnostic apparatus for testing food; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Apparatus for transmitting and reproducing images, namely, spectrocolorimeters, other than for medical diagnostic use; semiconductor testing apparatus for diagnostic purposes, other than medical; Diagnostic apparatus for the detection of pathogens, namely, testing apparatus for diagnostic purposesACTIVE—
010Medical diagnostic apparatus for testing for viruses; Ultrasound apparatus for veterinary use; X-ray diagnostic apparatus for carrying-out tests for medical purposes; Ultrasound diagnostic apparatus for medical purposes; Ultrasonic medical diagnostic apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic test media in the form of strips for measuring blood glucose levels; Medical diagnostic apparatus for testing antibodies for use in immunoassay procedures; Medical diagnostic instruments for the analysis of body fluids for use in immunoassay procedure; Medical diagnostic apparatus for detecting cancer; Medical instrument for cardiovascular diagnostics; Sensory testing instruments, namely, aesthesiometers for medical diagnostic purposes; Testing probes for medical diagnostic purposes; Diagnostic pen lights for medical purposes; Medical diagnostic instruments for the analysis of body fluids, namely, urine testingACTIVE—
042Food safety testing; Product design and development in the field of medical diagnostic apparatus; Consulting services in the field of hosting computer software applications; Consultancy and information services in the field of information technology; Consultancy and information services in the field of information technology architecture and infrastructure; Consultancy and information services relating to computer programming; Consultancy and information services relating to computer software design; Consultancy and information services relating to information technology; Consultancy and information services relating to software maintenance; Consultancy in the field of biotechnology; Consultancy in the field of computer software; Consultancy in the field of scientific research; Consultancy in the field of software design; Consultancy in the field of technological design; Consultancy in the field of technological research; Consultancy relating to biotechnology; Consultancy relating to pharmaceutical research and development; Consultancy relating to software design and development; Consultancy services in the field of technological development; Consultancy services relating to information technology; Consultancy services relating to product engineering; Consultancy services relating to technological researchACTIVE—
044Medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes, namely, optical imaging; Medical diagnostic testing, monitoring and reporting services; Providing medical information, consultancy and advisory services relating to medical products; health care consulting in the field of optical imaging; Wellness and health-related consulting services, namely, relating to nutritionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 7, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 7, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 7, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 7, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 7, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 22, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 22, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 2, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 20, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2021XAECEXAMINER'S AMENDMENT ENTERED—
May 19, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 19, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
May 19, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
May 17, 2021XAECEXAMINER'S AMENDMENT ENTERED—
May 17, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 17, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
May 17, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
May 15, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 15, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 15, 2021ALIEASSIGNED TO LIE—
Feb 5, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2020DOCKASSIGNED TO EXAMINER—
May 15, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance